Department of Preclinical and Clinical Pharmacology, University of Florence, Florence, Italy.
Mol Pharmacol. 2011 Jun;79(6):932-40. doi: 10.1124/mol.110.070110. Epub 2011 Mar 11.
Poly(ADP-ribose) polymerase-1 (PARP-1) is a NAD-consuming enzyme with an emerging key role in epigenetic regulation of gene transcription. Although PARP-1 expression is characteristically restricted to the nucleus, a few studies report the mitochondrial localization of the enzyme and its ability to regulate organelle functioning. Here, we show that, despite exclusive nuclear localization of PARP-1, mitochondrial homeostasis is compromised in cell lines exposed to PARP-1 pharmacological inhibitors or small interfering RNA. PARP-1 suppression reduces integrity of mitochondrial DNA (mtDNA), as well as expression of mitochondria-encoded respiratory complex subunits COX-1, COX-2, and ND-2. Accordingly, PARP-1 localizes at promoters of nuclear genes encoding both the mtDNA repair proteins UNG1, MYH1, and APE1 and the mtDNA transcription factors TFB1M and TFB2M. It is noteworthy that poly(ADP-ribosyl)ation is required for nuclear gene expression of these mitochondrial proteins. Consistent with these findings, PARP-1 suppression impairs mitochondrial ATP production. Our results indicate that PARP-1 plays a central role in mitochondrial homeostasis by epigenetically regulating nuclear genes involved in mtDNA repair and transcription. These data might have important implications in pharmacology of PARP-1 inhibitors as well as clinical oncology and aging.
聚(ADP-核糖)聚合酶 1(PARP-1)是一种 NAD 消耗酶,在基因转录的表观遗传调控中具有新兴的关键作用。尽管 PARP-1 的表达特征限于细胞核,但有几项研究报道了该酶的线粒体定位及其对细胞器功能的调节能力。在这里,我们表明,尽管 PARP-1 具有独特的核定位,但暴露于 PARP-1 药理学抑制剂或小干扰 RNA 的细胞系中线粒体的动态平衡受到损害。PARP-1 抑制降低了线粒体 DNA(mtDNA)的完整性,以及线粒体编码呼吸复合物亚基 COX-1、COX-2 和 ND-2 的表达。相应地,PARP-1 定位于编码 mtDNA 修复蛋白 UNG1、MYH1 和 APE1 以及 mtDNA 转录因子 TFB1M 和 TFB2M 的核基因的启动子。值得注意的是,这些线粒体蛋白的核基因表达需要聚(ADP-核糖)化。这些发现表明,PARP-1 通过表观遗传调节参与 mtDNA 修复和转录的核基因,在维持线粒体动态平衡中发挥核心作用。这些数据可能对 PARP-1 抑制剂的药理学以及临床肿瘤学和衰老具有重要意义。